MDEChem, Inc.
MDKM
OTC PK
| 03/31/2012 | |||||
|---|---|---|---|---|---|
| Revenue | -97.94% | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -97.94% | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -97.79% | ||||
| SG&A Expenses | 48.33% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -48.55% | ||||
| Operating Income | -103.54% | ||||
| Income Before Tax | -104.02% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -104.35% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -104.35% | ||||
| EBIT | -103.54% | ||||
| EBITDA | -- | ||||
| EPS Basic | -120.42% | ||||
| Normalized Basic EPS | -- | ||||
| EPS Diluted | -120.42% | ||||
| Normalized Diluted EPS | -- | ||||
| Average Basic Shares Outstanding | -- | ||||
| Average Diluted Shares Outstanding | 0.00% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
